Skip to content
MedsAcross

Molecule

Acoltremon

Available on requestCold chain
Presentations
1
Brands
1
Manufacturers
1
Available from stock
0

Acoltremon is a TRPM8 thermoreceptor agonist indicated for the treatment of the signs and symptoms of dry eye disease. It is available as ophthalmic solution for topical use. MedsAcross supplies Acoltremon for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

US FDA first approval
28 May 2025
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Ophthalmic, Topical
Dosage forms
Ophthalmic solution
Identifiers
UNII 1L7BVT4Z4ZCAS 68489-09-8DrugBank DB19202Q27089230

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

TRYPTYR is indicated for the treatment of the signs and symptoms of dry eye disease. TRYPTYR is a TRPM8 thermoreceptor agonist indicated for the treatment of the signs and symptoms of dry eye disease.

Source: US FDA prescribing information

How it works

Studies in animals suggest that acoltremon, the active substance in TRYPTYR, is an agonist of transient receptor potential melastatin 8 (TRPM8) thermoreceptors. TRPM8 thermoreceptor stimulation has been shown to activate trigeminal nerve signaling leading to increased basal tear production. The exact mechanism of action for TRYPTYR in dry eye disease is unknown.

Source: US FDA prescribing information

Dosing overview

Instill one drop in each eye twice daily (approximately 12 hours apart). Recommended Dosage Instill one drop in each eye twice daily (approximately 12 hours apart).

Source: US FDA prescribing information

Warnings and precautions

To avoid the potential for eye injury and contamination, do not touch the vial tip to the eye or other surfaces. Potential for Eye Injury and Contamination To avoid the potential for eye injury and contamination, do not touch the vial tip to the eye or other surfaces. Use with Contact Lenses TRYPTYR should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following administration of TRYPTYR.

Source: US FDA prescribing information

Storage

Storage Store refrigerated at 2°C to 8°C (36°F to 46°F). If stored at room temperature, TRYPTYR should be used within 30 days, not to exceed the expiration date printed on the carton and foil pouch. After opening the carton, TRYPTYR may be stored refrigerated or at room temperature at 2°C to 25°C (36°F to 77°F). Store unopened single-dose vials in the original foil pouch until ready to use.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

1 presentations of Acoltremon, sorted by availability.

MedicineManufacturerRegisterAvailability
Tryptyr 0.03 mg/mL ophthalmic solutionOphthalmic, topical Cold chainAlcon LaboratoriesUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 28 May 2025Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Acoltremon available for export from India?

Yes, on request. MedsAcross lists 1 presentations of Acoltremon and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Acoltremon have?

The catalogue lists 1 brand names for Acoltremon, including Tryptyr.

Is Acoltremon approved by the US FDA?

Yes. The US FDA first approved Acoltremon on 28 May 2025, according to Drugs@FDA.

Does Acoltremon need cold chain shipping?

At least one listed presentation of Acoltremon must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.

References

  1. TRYPTYR prescribing information (Alcon Laboratories). U.S. National Library of Medicine, DailyMed. Retrieved 18 December 2025

Request Acoltremon for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.